Inventor · disambiguated record
Veerle Snoeck
Also filed as: SNOECK VEERLE
20 granted patents·5 pending applications·59 citations·filing 2006–2023
93Inventor score
Top patents by PatentIndex Score
25 records- 0197US10858418B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Dec 8, 2020·18 cites·20 claims
- 0293US11009511B2Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodiesABLYNX NV·Filed 2015·Granted May 18, 2021·6 cites·7 claims
- 0392US11192937B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·6 claims
- 0492US11192938B2Serum albumin binding proteins containing immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·35 claims
- 0587US9328174B2Chemokine receptor binding polypeptidesNOVARTIS AG·Filed 2013·Granted May 3, 2016·8 cites·11 claims
- 0685US12006352B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Jun 11, 2024·1 cites·6 claims
- 0785US2023242620A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2023·Application pending·0 cites
- 0883US8398995B2Method of inducing immune tolerance to type I diabetesROTTIERS PIETER·Filed 2009·Granted Mar 19, 2013·5 cites·23 claims
- 0981US11644471B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2013·Granted May 9, 2023·2 cites·9 claims
- 1079US8524246B2Treatment of immune disease by mucosal delivery of antigents using genetically modified LactobacillusACTOGENIX NV·Filed 2012·Granted Sep 3, 2013·3 cites·15 claims
- 1177US9539291B2Induction of mucosal tolerance to antigensINTREXON ACTOBIOTICS NV·Filed 2014·Granted Jan 10, 2017·2 cites·43 claims
- 1277US8748126B2Induction of mucosal tolerance to antigensROTTIERS PIETER·Filed 2006·Granted Jun 10, 2014·2 cites·33 claims
- 1372US10668136B2Treatment of immune disease by mucosal delivery of antigens using genetically modified LactococcusINTREXON ACTOBIOTICS NV·Filed 2018·Granted Jun 2, 2020·0 cites·16 claims
- 1471US9688763B2Chemokine receptor binding polypeptidesNOVARTIS AG·Filed 2015·Granted Jun 27, 2017·1 cites·10 claims
- 1569US11059899B1Polypeptides that bind glucocorticoid-induced TNFR family-related receptor (GITR)ABLYNX NV·Filed 2016·Granted Jul 13, 2021·1 cites·17 claims
- 1666US2018355031A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2018·Application pending·0 cites
- 1764US9526750B2Induction of mucosal tolerance to antigensINTREXON ACTOBIOTICS NV·Filed 2014·Granted Dec 27, 2016·0 cites·30 claims
- 1862US2018009888A9Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsBAUMEISTER JUDITH·Filed 2012·Application pending·0 cites
- 1961US10195269B2Induction of mucosal tolerance to antigensINTREXON ACTOBIOTICS NV·Filed 2016·Granted Feb 5, 2019·0 cites·29 claims
- 2061US10143729B2Treatment of immune disease by mucosal delivery of antigens using genetically modified LactococcusINTREXON ACTOBIOTICS NV·Filed 2013·Granted Dec 4, 2018·0 cites·33 claims
- 2156US11919966B2Methods for inhibiting tumor growth or treating cancer by administering an immunoglobulin single variable domain that binds glucocorticoid-induced TNFR family-related receptor (GITR)ABLYNX NV·Filed 2021·Granted Mar 5, 2024·0 cites·20 claims
- 2254US11466089B2Chemokine receptor binding polypeptidesABLYNX NV·Filed 2017·Granted Oct 11, 2022·0 cites·10 claims
- 2343US2019195866A1Improved pharmacokinetic assays for immunoglobulin single variable domainsABLYNX NV·Filed 2017·Application pending·0 cites
- 2442US12480957B2Method of screening for anti-drug antibodies against immunoglobulin single variable domain-based drugsABLYNX NV·Filed 2018·Granted Nov 25, 2025·0 cites·14 claims
- 2537US2015344568A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Veerle Snoeck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →